Reduction of portosystemic gradient during transjugular intrahepatic portosystemic shunt achieves good outcome and reduces complications

Figure 1 Total primary unassisted patency rates of four groups. The total primary unassisted patency rates were not significantly different.

Figure 2 Hepatic function compromise after transjugular intrahepatic portosystemic shunt. The probability of total hepatic impairment differed significantly between groups A and B, and C and D.

Figure 3 Recurrent variceal bleeding after transjugular intrahepatic portosytemic shunt. Patients in groups A and B had recurrent variceal bleeding, and there was no significant difference between the groups.

Figure 4 Recurrent ascites after transjugular intrahepatic portosytemic shunt of groups C and D. Patients in groups C and D had recurrent ascites, with a significant difference between the groups.

Figure 5 Incidence of hepatic encephalopathy after transjugular intrahepatic portosytemic shunt. The incidence of HE differed significantly in group A compared with group B, and in group C compared with group D at different times. HE: Hepatic encephalopathy.

Figure 6 The survival rates of four groups. The total survival rates were not different between groups A and B, but differed significantly between groups C and D.